Showing results (261-270 of 285) with videos related to
Sort By:
Pageof 29
World Journal of Gastroenterology|January 27, 2006
Relationship between body surface area and ALT normalization after long-term lamivudine treatmentMakoto Nakamuta, Shusuke Morizono, Yuichi Tanabe, et al.BMJ Open|June 22, 2019
Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in JapanAtaru Igarashi, Norihiro Furusyo, Eiichi Ogawa, et al.Respiratory Medicine Case Reports|July 21, 2025
Empyema associated with Actinomyces georgiae successfully treated with multimodal therapy including surgical intervention: A first case reportSenichi Fukuda, Yuya Homma, Hiroki Kawakami, et al.Journal of Gastroenterology and Hepatology|April 16, 2014
Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosisEiichi Ogawa, Norihiro Furusyo, Makoto Nakamuta, et al.Plos One|March 7, 2024
Lower doses of carvedilol in Japanese heart failure patients with reduced ejection fraction could show the potential to be non-inferior to higher doses in US patients: An international collaborative observational studyMakiko Maeda, Douglas Humber, Eisuke Hida, et al.International Urology and Nephrology|March 18, 2016
The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS)Motohiro Shimizu, Norihiro Furusyo, Yuuki Tanaka, et al.Biorxiv : the Preprint Server for Biology|February 12, 2026
ACE-2-like Enzymatic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal AntibodiesYufeng Song, Frances Mehl, Tom No, et al.BMJ Open|November 22, 2019
Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre studyToshio Naito, Mika Tanei, Nobuhiro Ikeda, et al.Journal of Gastroenterology and Hepatology|February 3, 2025
Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting AntiviralsEiichi Ogawa, Akira Kawano, Motoyuki Kohjima, et al.Journal of Gastroenterology and Hepatology|August 9, 2025
Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal ImpairmentEiichi Ogawa, Motoyuki Kohjima, Toshimasa Koyanagi, et al.Pageof 29